BP
EXAS

Ballentine Partners’s Exact Sciences EXAS Stock Holding History

Ballentine Partners’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,570
Closed -$363K – 1045
2025
Q4 		$363K Sell
3,570
-427
-11% -$34.3K 0.01% 635
2025
Q3 		$219K Sell
3,997
-841
-17% -$42K ﹤0.01% 870
2025
Q2 		$257K Buy
+4,838
New +$246K ﹤0.01% 760
2024
Q4 		– Sell
-3,399
Closed -$232K – 910
2024
Q3 		$232K Buy
+3,399
New +$192K ﹤0.01% 696
2023
Q3 		– Sell
-2,462
Closed -$231K – 620
2023
Q2 		$231K Buy
+2,462
New +$192K 0.01% 514

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.46B AUM 22.77% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Ballentine Partners's EXAS Position: Q1 2026 in Review

Ballentine Partners sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 3,570 shares — an estimated $363K sold.

Ballentine Partners first reported a position in EXAS in Q2 2023 and held it in 5 quarters. The position peaked at $363K in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Ballentine Partners reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Ballentine Partners sold 3,570 Exact Sciences shares in Q1 2026, an estimated $363K.
  • Ballentine Partners first reported a position in Exact Sciences in Q2 2023 and held it in 5 quarters.
  • Ballentine Partners's Exact Sciences position peaked at $363K in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Ballentine Partners's 13F filing for Q1 2026, filed 14 May 2026.